Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  INNATE PHARMA    IPH   FR0010331421

INNATE PHARMA

 (IPH)

344
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Upcoming events on INNATE PHARMA
06/28/13 Annual General Meeting
09/19/13 Q2 2013 Earnings Release
11/05/13 Q3 2013 Sales and Revenue Release

Past events on INNATE PHARMA
05/07/13 Q1 2013 Sales and Revenue Release
03/06/13 Credit Suisse Global Healthcare Conference
03/05/13 | 10:00am Q4 2012 Earnings Call
03/05/13 Q4 2012 Earnings Release
Annual publications
Previous yearNext Year
Annual results2010201120122013 (e)2014 (e)
Sales
Million €
Released
Forecast
Spread
4,32
4,70
-8,1%
11,7
28,4
-59%
14,3
7,02
103%

6,98

5,58
Operating income (EBITDA)
Million €
Released
Forecast
Spread
-14,8
-18,8
21%
-6,65
3,00
-322%
-2,55
-5,10
50%

-3,60

-7,09
Operating profit (EBIT)
Million €
Released
Forecast
Spread
-13,7
-20,8
34%
-7,57
1,40
-641%
-3,39
-6,00
44%

-4,42

-7,88
Pre-Tax Profit (EBT)
Million €
Released
Forecast
Spread




-3,20
-6,09
48%

-4,69

-8,26
Net income
Million €
Released
Forecast
Spread


-6,98
-10,0
30%
-3,20
-6,09
48%

-4,74

-8,31
EPS
 €
Released
Forecast
Spread
-0,36

-0,19
-0,25
24%
-0,08
-0,16
50%

-0,13

-0,22
Announcement Date03/02/201103/06/201203/05/2013

© 2013 Thomson Reuters
© 2013 Factset
Advertisement
Net sales - Rate of surprise
INNATE PHARMA : Net sales - Rate of surprise
Operating profit - Rate of surprise
INNATE PHARMA : Operating profit - Rate of surprise
EPS - Rate of surprise
INNATE PHARMA : EPS - Rate of surprise
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.